MAP2K7 and leukemia: To identify upstream mediators of MEK phosphorylation other than Raf, we evaluated the activity of SFKs, which are often overexpressed/overactive in Bcr‐Abl1‐positive leukemia cells (Fig. 3C, Fig. S2C).